Nitrase Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nitrase Therapeutics's estimated annual revenue is currently $2.2M per year.
- Nitrase Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Nitrase Therapeutics has 29 Employees.
- Nitrase Therapeutics grew their employee count by -22% last year.
Nitrase Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO/CSO | Reveal Email/Phone |
2 | Sr. VP, Biology and Head Oncology | Reveal Email/Phone |
3 | VP Drug Discovery | Reveal Email/Phone |
4 | Prinicipal Scientist | Reveal Email/Phone |
5 | Operations Associate II | Reveal Email/Phone |
6 | Scientist | Reveal Email/Phone |
7 | Senior Research Associate - Assay Development | Reveal Email/Phone |
8 | Accounts Payable Assistant I | Reveal Email/Phone |
9 | Senior Research Associate | Reveal Email/Phone |
10 | Associate Director/Senior Manager/Senior Scientist | Reveal Email/Phone |
Nitrase Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Nitrase Therapeutics?
Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes that it discovered, to develop a pipeline of therapies against a broad variety of diseases. The medicines that Nitrase Therapeutics is developing will target these enzymes and potentially help slow or halt the progression of a wide variety of diseases in which nitrases and nitro-substrates play a role, including Parkinson’s and cancer. Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).
keywords:N/A
N/A
Total Funding
29
Number of Employees
$2.2M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Brisbane
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 29 | -15% | N/A |
#2 | $5.4M | 30 | 0% | N/A |
#3 | $3.5M | 30 | N/A | N/A |
#4 | $6.5M | 30 | 7% | N/A |
#5 | $6.7M | 31 | 0% | N/A |